Copyright
©The Author(s) 2021.
World J Clin Cases. Apr 16, 2021; 9(11): 2533-2541
Published online Apr 16, 2021. doi: 10.12998/wjcc.v9.i11.2533
Published online Apr 16, 2021. doi: 10.12998/wjcc.v9.i11.2533
Variable | Reference range | First visit | Second hospitalisation | Third hospitalisation | Forth hospitalisation | Last dose of chemotherapy |
CEA (ng/mL) | 0-3.4 | 44.04 | 28.69 | 17.18 | 5.67 | 3.21 |
CA242 (IU/mL) | 0-15 | 18.08 | 14.45 | 10.81 | 7.85 | 8.52 |
CA19-9 (U/mL) | 0-39 | 100.8 | 60.81 | 33.83 | 18.39 | 16.70 |
AFP (ng/mL) | 0-7.02 | 9.03 | 8.09 | 7.16 | 6.15 | 6.75 |
CA15-3 (U/mL) | 0-25 | 30.37 | 22.58 | 20.13 | 15.84 | 14.70 |
CA125 (U/mL) | 0-35 | 137.4 | 40.68 | 21.11 | 11.66 | 12.10 |
HE4 (pmol/L) | < 140 | 105.7 | 72.3 | 70.1 | 64.4 | 50.7 |
- Citation: Wang Q, Niu XY, Feng H, Wu J, Gao W, Zhang ZX, Zou YW, Zhang BY, Wang HJ. Gastrointestinal-type chemotherapy prolongs survival in an atypical primary ovarian mucinous carcinoma: A case report. World J Clin Cases 2021; 9(11): 2533-2541
- URL: https://www.wjgnet.com/2307-8960/full/v9/i11/2533.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i11.2533